Reduced Response Rates after Therapy Change from Adalimumab Originator to Biosimilar ABP 501 in Patients with Hidradenitis suppurativa - Results from the German Hidradenitis suppurativa Registry HSBest
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要